Back to mobile site

Akorn (AKRX) Confirms Adverse Court Ruling Related to Fresenius Deal, Plans to Appeal

October 1, 2018 9:27 AM EDT Send to a Friend
Akorn, Inc. (NASDAQ: AKRX), today issued the following statement in response to the ruling by the Delaware Chancery ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login